Exagen board member James Tullis to resign at 2023 annual meeting

EXAGEN INC.

James L.L. Tullis notified Board on March 20, 2023 of resignation effective at the 2023 annual meeting.
Resignation is not due to any disagreement with the Company or Board.
No replacement has been announced for the departing director.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James L.L. Tullis

Director

XGN · EXAGEN INC.

Filed: March 23, 2023, 7:59 PM ET

On March 20, 2023, James L.L. Tullis informed the Board of Directors (the 'Board') of Exagen Inc. (the 'Company') that he will resign from the Board effective at the Company's 2023 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James L.L. Tullis resigned as Director at EXAGEN INC..

Action: resigned
Role: Director

Exact text from the filing

On March 20, 2023, James L.L. Tullis informed the Board of Directors (the 'Board') of Exagen Inc. (the 'Company') that he will resign from the Board effective at the Company's 2023 annual meeting of stockholders.

View on SEC.gov

EXAGEN INC. filing history →

Source: SEC EDGAR

accession 0001274737-23-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.